Abstract
Treatment of Primary Plasma Cell Leukemia with Carfilzomib and Lenalidomide-Based Therapy: Results of the First Interim Analysis of the Phase 2 EMN12/HOVON129 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have